Anavex Life Sciences Corp (AVXL)

[falconer66a]

Matches my share price projections.

SP = ( 0.5 x $25B x 20 ) / 100M = $2498.00

Those are well within the realm of numbers my determining diligence renders. In a few years, an AVXL share price will be in range of $2000 to $2500.

In ten years? After Anavex has three or four sigma-1 receptor agonists approved for a diversity of CNS and other diseases, especially for prophylactic uses (anti-aging, geriatric disease prevention, etc.) the share price could be multiples of the price in four years.

Recently, I've been dutiful, however, in not posting either the price projections I've come up with or exactly the reasons I used to determine them. Those few who would both understand and apply those reasons have already done so, using the information they've derived from the many useful postings by so many. But most would look at my numbers and reasons --- just as they do with this present projection --- as merely dubious and unsupported hope.

I'll be checking back, even posting, how I've done at the end of 2023. Next year will be Anavex's break away year. I'll be telling if my reasons for the AVXL price expansion have been validated. The top line results from the three big clinical trials for Rett, Parkinson's disease dementia, and Alzheimer's will be the validating story. Gonna be fun.